Key Takeaways
- Boehringer Ingelheim received an FDA Emergency Use Authorization (EUA) for IVOMEC® (ivermectin) 1% Injection.
- The authorization covers prevention of New World screwworm infestations in cattle at critical intervention points.
- This is the first EUA issued for an over-the-counter drug for NWS prevention in cattle.
- The authorization applies only during the declared emergency period and excludes certain cattle categories.
- The decision follows confirmed NWS cases in northern Mexico near the U.S. border.
Boehringer Ingelheim Granted FDA Emergency Use Authorization
Boehringer Ingelheim, a global animal health company, announced that the U.S. Food and Drug Administration has issued an Emergency Use Authorization for IVOMEC® (ivermectin) 1% Injection for the prevention of infestations caused by New World screwworm (Cochliomyia hominivorax) in cattle.
Under the EUA, IVOMEC® (ivermectin) 1% Injection is authorized for use when administered within 24 hours of birth, at the time of castration, or at the appearance of a wound. The authorization excludes female dairy cattle producing milk for human consumption and calves intended for veal production. According to the FDA, there is no adequate, approved, and available alternative for preventing NWS infestations at these critical intervention points.
This marks the first Emergency Use Authorization for any over-the-counter drug aimed at preventing NWS infestations in cattle, providing access to a preventive option should an incursion occur in the United States.
